Get the Stockscreener App
5.30
3.81%
-0.21
After Hours:
5.38
0.08
+1.51%
Clene Inc stock is traded at $5.30, with a volume of 37,468.
It is down -3.81% in the last 24 hours and up +35.20% over the past month.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
See More
Previous Close:
$5.51
Open:
$5.41
24h Volume:
37,468
Relative Volume:
0.23
Market Cap:
$62.43M
Revenue:
$442.00K
Net Income/Loss:
$-30.46M
P/E Ratio:
-1.1883
EPS:
-4.46
Net Cash Flow:
$-27.47M
1W Performance:
-1.12%
1M Performance:
+35.20%
6M Performance:
-12.11%
1Y Performance:
+20.45%
1-Day Range:
$5.25
$5.57
1-Week Range:
$4.80
$5.57
52-Week Range:
$2.2801
$13.50
Clene Inc Stock (CLNN) Company Profile
Name
Clene Inc
Sector
Industry
Phone
801-676-9695
Address
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
5.30 | 64.90M | 442.00K | -30.46M | -27.47M | -4.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-04-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-22 | Initiated | H.C. Wainwright | Buy |
| May-02-22 | Initiated | Canaccord Genuity | Buy |
| Sep-28-21 | Initiated | Oppenheimer | Outperform |
Clene Inc Stock (CLNN) Latest News
Nanotechnology Stocks To Follow NowMarch 4th - MarketBeat
CLNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Investor Mood: Is Clene Inc Equity Warrant stock undervalued right nowPortfolio Performance Report & AI Driven Stock Movement Reports - baoquankhu1.vn
Best Nanotechnology Stocks Worth WatchingMarch 3rd - MarketBeat
Promising Nanotechnology Stocks To Follow TodayMarch 2nd - MarketBeat
Top Nanotechnology Stocks To ConsiderMarch 1st - MarketBeat
Update Recap: Is Clene Inc a play on infrastructure spendingJuly 2025 Retail & Stock Portfolio Risk Management - baoquankhu1.vn
CLNN Should I Buy - Intellectia AI
Aug Swings: Is LXRX gaining market sharePortfolio Value Report & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Clene Touts FDA Path for ALS Drug CNM-Au8, Highlights Biomarkers, Extends Cash Runway - MarketBeat
CLNN: Strong biomarker and survival data for ALS therapy positions company for NDA filing and 2027 launch - TradingView
CLNN: Strong biomarker and survival data support accelerated ALS approval, with NDA filing by Q2 - TradingView
CLNN SEC FilingsClene 10-K, 10-Q, 8-K Forms - Stock Titan
Risks Report: What is the Moat Score of Clene IncJuly 2025 Chart Watch & Growth Focused Stock Reports - baoquankhu1.vn
Nanotechnology Stocks To Watch NowFebruary 24th - MarketBeat
Growth Recap: What chart patterns are forming on Clene Inc Equity WarrantWeekly Trade Analysis & AI Enhanced Execution Alerts - baoquankhu1.vn
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts - Investing News Network
Clene outlines 2026 regulatory milestones and ALS strategy - TipRanks
Clene (CLNN) Outlines Key Developments for CNM-Au8 in 2026 - GuruFocus
Clene Inc. Outlines Key Milestones for 2026 - Intellectia AI
Experimental ALS drug CNM-Au8 heads toward 2026 FDA review - Stock Titan
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream - Investing News Network
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8 2026 Catalysts - Bitget
Nanotechnology Stocks Worth WatchingFebruary 23rd - MarketBeat
Top Nanotechnology Stocks To ResearchFebruary 21st - MarketBeat
Chart Watch: What are the analyst revisions for INCYIs Clene Inc stock a good investment in YEAREarnings Recap Report & Weekly High Return Stock Opportunities - baoquankhu1.vn
Clene (CLNN) director awarded 4,098 stock options in Form 4 filing - Stock Titan
Published on: 2026-02-20 10:15:16 - baoquankhu1.vn
Clene to Present at the Emerging Growth Conference - Investing News Network
Best Nanotechnology Stocks Worth Watching – February 16th - Defense World
When Will Clene Inc. (NASDAQ:CLNN) Turn A Profit? - Yahoo Finance
Is Clene Inc. a play on infrastructure spending2025 Performance Recap & Risk Controlled Daily Trade Plans - mfd.ru
Nanotechnology Stocks To ConsiderFebruary 15th - MarketBeat
Valuation Update: Is Clene Inc a strong growth stockJuly 2025 PostEarnings & Real-Time Buy Signal Notifications - baoquankhu1.vn
Can Clene Inc. Equity Warrant ride the EV waveJuly 2025 Spike Watch & Fast Exit and Entry Strategy Plans - mfd.ru
Is Clene Inc. Equity Warrant stock a smart retirement pick2025 Trading Recap & Consistent Profit Focused Trading Strategies - mfd.ru
Can Clene Inc. maintain its current growth rate2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru
Is Clene Inc. Equity Warrant stock positioned for long term growthJuly 2025 PreEarnings & Community Consensus Picks - mfd.ru
Can Clene Inc. Equity Warrant stock maintain operating marginsJuly 2025 Catalysts & Short-Term Swing Trade Alerts - mfd.ru
Is Clene Inc. Equity Warrant exposed to currency risks2025 Retail Activity & Growth Focused Investment Plans - mfd.ru
Promising Nanotechnology Stocks To Add to Your WatchlistFebruary 10th - MarketBeat
Performance Recap: Whats the profit margin of Clene Inc Equity Warrant2025 Investor Takeaways & Accurate Trade Setup Notifications - baoquankhu1.vn
Top Nanotechnology Stocks To Follow NowFebruary 7th - MarketBeat
Nanotechnology Stocks To Keep An Eye On – February 3rd - Defense World
Aug Patterns: Is Clene Inc Equity Warrant a good stock for dollar cost averaging2025 Risk Factors & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Nanotechnology Stocks To Consider – February 2nd - Defense World
Nanotechnology Stocks To Keep An Eye OnFebruary 3rd - MarketBeat
Stock Market Recap: Is Clene Inc a strong growth stockEarnings Growth Summary & Verified Swing Trading Watchlists - baoquankhu1.vn
Published on: 2026-02-03 15:42:06 - baoquankhu1.vn
Tech Rally: Should I invest in Clene Inc before earnings2025 Market WrapUp & Reliable Breakout Forecasts - baoquankhu1.vn
Aug Spikes: What dividend growth rate does RIBB offerDip Buying & Accurate Entry/Exit Alerts - baoquankhu1.vn
Clene Inc Stock (CLNN) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):